Annual report pursuant to Section 13 and 15(d)

Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares

v3.22.1
Summary of Significant Accounting Policies (Details) - Schedule of anti dilutive common shares - shares
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Schedule of anti dilutive common shares [Abstract]    
Options 2,741,000 50,000
Warrants 11,153,908 6,064,908
Convertible debt [1] 932,614
Total potentially dilutive shares 13,894,908 7,047,522
[1] Represents shares issuable upon conversion of debt at various conversion prices, some of which were calculated using the fair value of the Company’s common stock at the respective balance sheet date.